NGL Fine Chem Ltd

nglfinechem.com BSE: 524774
About

NGL Fine Chem is engaged in the Business of Chemical substances used in manufacture of pharmaceuticals and Allopathic medicines.

Website BSE
  • Market Cap ₹ 812 Cr.
  • Current Price ₹ 1,314
  • High / Low ₹ 1,343 / 220
  • Stock P/E 31.5
  • Book Value ₹ 200
  • Dividend Yield 0.13 %
  • ROCE 15.4 %
  • ROE 12.5 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is expected to give good quarter

Cons

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
29 32 35 39 34 43 41 37 37 35 42 68
24 26 30 32 27 33 32 33 34 33 30 49
Operating Profit 5 6 5 7 7 11 9 5 4 2 13 19
OPM % 18% 18% 15% 18% 21% 25% 21% 13% 10% 6% 30% 27%
Other Income 2 1 2 2 1 1 1 1 1 1 2 3
Interest 1 1 1 1 1 1 0 1 1 1 1 1
Depreciation 1 1 2 1 2 2 2 2 2 2 2 2
Profit before tax 6 4 5 7 6 10 8 3 3 1 12 19
Tax % 27% 31% 7% 34% 30% 30% 29% 12% 22% 79% 28% 23%
Net Profit 4 3 5 4 4 7 6 3 2 0 9 15
EPS in Rs 6.78 4.97 7.80 7.15 6.59 11.02 8.97 4.81 3.29 0.23 14.33 23.96
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
25 30 35 36 56 79 88 96 100 114 153 152 184
21 25 30 32 48 68 73 74 74 92 121 129 146
Operating Profit 4 5 5 4 8 11 15 22 25 22 32 23 37
OPM % 17% 16% 14% 11% 14% 14% 17% 23% 26% 19% 21% 15% 20%
Other Income 0 0 0 0 0 -1 2 0 1 3 4 1 7
Interest 1 0 1 1 1 2 2 2 1 2 3 3 2
Depreciation 1 1 1 1 2 2 3 3 3 5 6 7 7
Profit before tax 3 4 4 2 4 7 13 18 23 18 28 14 35
Tax % 38% 31% 37% 32% 35% 32% 35% 36% 35% 29% 27% 26%
Net Profit 2 3 2 1 3 5 8 11 15 13 20 11 26
EPS in Rs 3.17 4.37 3.92 1.70 4.71 7.33 13.48 18.45 24.10 20.38 32.58 17.16 41.81
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 5% 10%
Compounded Sales Growth
10 Years:18%
5 Years:12%
3 Years:15%
TTM:18%
Compounded Profit Growth
10 Years:16%
5 Years:11%
3 Years:-7%
TTM:33%
Stock Price CAGR
10 Years:51%
5 Years:32%
3 Years:50%
1 Year:215%
Return on Equity
10 Years:21%
5 Years:21%
3 Years:18%
Last Year:13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions
Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
3 3 3 3 3 3 3 3 3 3 3 3 3
Reserves 8 11 13 14 17 21 30 41 56 69 89 98 120
Borrowings 4 5 6 10 13 17 13 14 23 27 27 28 24
5 7 9 10 14 15 21 19 20 31 23 26 44
Total Liabilities 20 25 32 37 47 56 67 78 102 129 142 156 192
6 6 11 10 18 19 17 24 25 56 61 61 59
CWIP 0 1 1 5 0 0 1 2 16 3 0 0 0
Investments 0 1 2 2 0 0 2 3 6 6 9 14 18
13 17 19 21 30 37 46 49 55 63 73 80 115
Total Assets 20 25 32 37 47 56 67 78 102 129 142 156 192

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
-0 1 4 1 -0 -0 8 8 10 22 9 20
-1 -2 -6 -4 -3 -4 -3 -10 -10 -21 -10 -20
2 1 1 3 4 3 -4 2 0 0 0 0
Net Cash Flow 0 -0 -0 -0 1 -1 1 0 -0 1 -1 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 27% 26% 22% 11% 19% 24% 29% 37% 34% 22% 28% 15%
Debtor Days 89 100 112 115 100 110 107 123 110 89 79 63
Inventory Turnover 4.28 3.56 4.37 4.07 4.22 4.87 4.45 4.04 3.86 3.62 4.11 3.26

Shareholding Pattern

Numbers in percentages

Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
65.45 65.45 65.45 65.45 65.45 65.45 65.45 73.83 73.83 73.81 73.81 73.81
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00
34.55 34.55 34.55 34.55 34.55 34.55 34.55 26.17 26.16 26.19 26.19 26.19

Documents

Add document

Recent announcements


View all

Annual reports

Credit ratings